MedTrace Logo

Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles

NCT04124913 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2019-10-14

No results posted yet for this study

Summary

The aim of this randomized controlled trial is to compare the efficacy of oral dydrogesterone vs. micronized vaginal progesterone for luteal phase support in frozen-thawed embryo transfer cycles.

Conditions

  • Infertility, Female
  • Infertility, Male
  • Embryo Transfer
  • Fertilization in Vitro
  • Drug Effect
  • Reproductive Techniques, Assisted
  • Progesterone
  • Dydrogesterone

Interventions

DRUG

Dydrogesterone 10 MG Oral Tablet

Oral dydrogesterone 10 mg tablet three times a day for luteal phase support

DRUG

Progesterone Vaginal Gel [Crinone]

Vaginal progesterone gel 90 mg once a day for luteal phase support

Sponsors & Collaborators

  • Memorial Sisli Hospital, Istanbul

    lead OTHER

Principal Investigators

  • Semra Kahraman, Prof · Memorial Şişli Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-02
Primary Completion
2019-10-31
Completion
2019-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04124913 on ClinicalTrials.gov